Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem Cell Transplantation vs Chemotherapy in ALL in First Remission
NCT00002514Phase 3Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- May 1993
- Primary completion
- Dec 2006
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Autologous Stem Cell Transplantation-Eastern Cooperative Oncology Group-acute lymphoblastic leukemia in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Eastern Cooperative Oncology Group. Primary endpoint: Overall Survival at 2 years. Started May 1993; status: completed.
02
Drugs
Autologous Stem Cell Transplantation-Eastern Cooperative Oncology Group-acute lymphoblastic leukemia
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00002514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002514.